Portfolio diversification is essential for 2025, says Peter Oppenheimer, Chief Global Equity Strategist at Goldman Sachs.
Goldman Sachs strategist Peter Oppenheimer discusses the outlook for equities in 2025 and areas where he sees opportunities ...
Upcoming patent expirations are driving pharmaceutical companies to acquire in 2025. In Sweden, we may be on our way to ...